Cite
Immunophenotypic Assessment of Minimal Residual Disease in Younger Acute Myeloid Leukemia Patients Is Highly Predictive of Outcome
MLA
Anant Gokarn, et al. “Immunophenotypic Assessment of Minimal Residual Disease in Younger Acute Myeloid Leukemia Patients Is Highly Predictive of Outcome.” Blood, vol. 132, Nov. 2018, p. 1498. EBSCOhost, https://doi.org/10.1182/blood-2018-99-116837.
APA
Anant Gokarn, Papagudi Ganesan Subramanian, Bhausaheb Bagal, Hari Menon, Sachin Punatar, Sitaram Ghogale, Chinmayee Kakirde, Dhanlaxmi Shetty, Nilesh Deshpande, Hasmukh Jain, Yajamanam Badrinath, Manju Sengar, Nikhil Rabade, Russel Mascarenhas, Shraddha Kadechkar, Nikhil Patkar, Shruti Chaudhary, Sumeet Gujral, Rohan Kodgule, … Prashant Tembhare. (2018). Immunophenotypic Assessment of Minimal Residual Disease in Younger Acute Myeloid Leukemia Patients Is Highly Predictive of Outcome. Blood, 132, 1498. https://doi.org/10.1182/blood-2018-99-116837
Chicago
Anant Gokarn, Papagudi Ganesan Subramanian, Bhausaheb Bagal, Hari Menon, Sachin Punatar, Sitaram Ghogale, Chinmayee Kakirde, et al. 2018. “Immunophenotypic Assessment of Minimal Residual Disease in Younger Acute Myeloid Leukemia Patients Is Highly Predictive of Outcome.” Blood 132 (November): 1498. doi:10.1182/blood-2018-99-116837.